Bruce & Co., Inc.

Holdings History for LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (LVTX)

Symbol: LVTX
Investment type: Equity / Common shares, Euro 0.12 nominal value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025		-0.22%	$0	0	-521,874	-100%	$1.74	Q3 2025
30 Jun 2025	0.22%	0%	$688,874	521,874	0		$1.32	Q2 2025
31 Mar 2025	0.21%	-0.1%	$662,780	521,874	-250,000		$1.27	Q1 2025
31 Dec 2024	0.24%	0%	$733,280	771,874	0		$0.95	Q4 2024
30 Sep 2024	0.37%	0%	$1,281,311	771,874	0		$1.66	Q3 2024
30 Jun 2024	0.46%	0%	$1,389,373	771,874	0		$1.80	Q2 2024
31 Mar 2024	0.85%	0%	$2,570,340	771,874	0		$3.33	Q1 2024
31 Dec 2023	0.43%	0%	$1,219,561	771,874	0		$1.58	Q4 2023
30 Sep 2023	0.39%	0%	$1,150,092	771,874	0		$1.49	Q3 2023
30 Jun 2023	0.44%	+0.06%	$1,566,904	771,874	+100,000	+15%	$2.03	Q2 2023
31 Mar 2023	0.3%	+0.26%	$1,115,311	671,874	+571,874	+572%	$1.66	Q1 2023
31 Dec 2022	0.09%	+0.09%	$350,000	100,000	+100,000	NEW	$3.50	Q4 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.